These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 36113831)
1. IGF2BP2 promotes the progression of ovarian endometriosis by regulating m6A-modified MEIS2 and GATA6. Zhao S; Zhang B; Yuan H; Yin Y; Qi S; Li W; Wu X; Yaling F Int J Biochem Cell Biol; 2022 Nov; 152():106296. PubMed ID: 36113831 [TBL] [Abstract][Full Text] [Related]
2. Exploring diagnostic m6A regulators in endometriosis. Jiang L; Zhang M; Wu J; Wang S; Yang X; Yi M; Zhang X; Fang X Aging (Albany NY); 2020 Nov; 12(24):25916-25938. PubMed ID: 33232273 [TBL] [Abstract][Full Text] [Related]
3. Transcriptome-wide N6-methyladenosine (m6A) methylation profiling of long non-coding RNAs in ovarian endometriosis. Liu H; Liang J; Dai X; Peng Y; Xiong W; Zhang L; Li X; Li W; Liu K; Bi S; Wang X; Zhang W; Liu Y Genomics; 2024 Mar; 116(2):110803. PubMed ID: 38290592 [TBL] [Abstract][Full Text] [Related]
4. N6-methyladenosine reader YTH N6-methyladenosine RNA binding protein 3 or insulin like growth factor 2 mRNA binding protein 2 knockdown protects human bronchial epithelial cells from hypoxia/reoxygenation injury by inactivating p38 MAPK, AKT, ERK1/2, and NF-κB pathways. Xiao K; Liu P; Yan P; Liu Y; Song L; Liu Y; Xie L Bioengineered; 2022 May; 13(5):11973-11986. PubMed ID: 34709120 [TBL] [Abstract][Full Text] [Related]
5. METTL3 facilitates prostate cancer progression via inducing HOXC6 m6A modification and stabilizing its expression through IGF2BP2-dependent mechanisms. He P; Liu X; Yu G; Wang Y; Wang S; Liu J; An Y Mol Cell Biochem; 2024 Jul; 479(7):1707-1720. PubMed ID: 38822192 [TBL] [Abstract][Full Text] [Related]
6. METTL3-regulated m6A modification impairs the decidualization of endometrial stromal cells by regulating YTHDF2-mediated degradation of FOXO1 mRNA in endometriosis-related infertility. Li X; Jin J; Long X; Weng R; Xiong W; Liang J; Liu J; Sun J; Cai X; Zhang L; Liu Y Reprod Biol Endocrinol; 2023 Oct; 21(1):99. PubMed ID: 37891533 [TBL] [Abstract][Full Text] [Related]
7. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner. Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of METTL3/m6A/miR126 promotes the migration and invasion of endometrial stromal cells in endometriosis†. Li X; Xiong W; Long X; Dai X; Peng Y; Xu Y; Zhang Z; Zhang L; Liu Y Biol Reprod; 2021 Nov; 105(5):1221-1233. PubMed ID: 34382070 [TBL] [Abstract][Full Text] [Related]
9. METTL3 facilitates tumor progression via an m Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592 [TBL] [Abstract][Full Text] [Related]
10. METTL3/IGF2BP2 axis affects the progression of colorectal cancer by regulating m6A modification of STAG3. Yi J; Peng F; Zhao J; Gong X Sci Rep; 2023 Oct; 13(1):17292. PubMed ID: 37828232 [TBL] [Abstract][Full Text] [Related]
11. METTL3-mediated m6A modification of SIRT1 mRNA inhibits progression of endometriosis by cellular senescence enhancing. Wang X; Wang J; Zhao X; Wu H; Li J; Cheng Y; Guo Q; Cao X; Liang T; Sun L; Zhang G J Transl Med; 2023 Jun; 21(1):407. PubMed ID: 37353804 [TBL] [Abstract][Full Text] [Related]
12. Genetic and pharmacological inhibition of METTL3 alleviates renal fibrosis by reducing EVL m6A modification through an IGF2BP2-dependent mechanism. Ni WJ; Zhou H; Lu H; Ma NN; Hou BB; Li W; Kong FX; Yu JT; Hou R; Jin J; Wen JG; Zhang T; Meng XM Clin Transl Med; 2023 Aug; 13(8):e1359. PubMed ID: 37537731 [TBL] [Abstract][Full Text] [Related]
13. Modulating the m6A Modified Transcription Factor GATA6 Impacts Epithelial Cytokines in Acute Lung Injury. Jin A; Li L; Zhao Y; Li M; Zhang S; Chen J; Li Y; Huang L; Ren H; Lu S; Yang X; Sun Q Am J Respir Cell Mol Biol; 2023 Nov; 69(5):521-532. PubMed ID: 37494067 [TBL] [Abstract][Full Text] [Related]
14. METTL3 is aberrantly expressed in endometriosis and suppresses proliferation, invasion, and migration of endometrial stromal cells. Zhang QC Kaohsiung J Med Sci; 2023 Mar; 39(3):266-277. PubMed ID: 36546578 [TBL] [Abstract][Full Text] [Related]
15. Cross-Talk between N6-Methyladenosine and Their Related RNAs Defined a Signature and Confirmed m6A Regulators for Diagnosis of Endometriosis. Wang X; Zhao X; Wang J; Wu H; Cheng Y; Guo Q; Liang T; Zhang G Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675186 [TBL] [Abstract][Full Text] [Related]
16. METTL3 and METTL14-mediated N Shen L; Zhang C; Zhang Y; Yang Y Reprod Biomed Online; 2023 Feb; 46(2):255-265. PubMed ID: 36517319 [TBL] [Abstract][Full Text] [Related]
17. Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7). Wei K; Gao Y; Wang B; Qu YX Bioengineered; 2022 Mar; 13(3):5236-5250. PubMed ID: 35156522 [TBL] [Abstract][Full Text] [Related]
18. Bioinformatic identification reveals a m6A-binding protein, IGF2BP2, as a novel tumor-promoting gene signature in thyroid carcinoma. Xie Y; Xiao J; Ying Y; Liu J; Zhang L; Zeng X Naunyn Schmiedebergs Arch Pharmacol; 2024 Aug; 397(8):5663-5676. PubMed ID: 38289368 [TBL] [Abstract][Full Text] [Related]
19. IGF2BP2 promotes pancreatic carcinoma progression by enhancing the stability of B3GNT6 mRNA via m6A methylation. Cao P; Wu Y; Sun D; Zhang W; Qiu J; Tang Z; Xue X; Qin L Cancer Med; 2023 Feb; 12(4):4405-4420. PubMed ID: 35908253 [TBL] [Abstract][Full Text] [Related]
20. The role of m6A RNA methylation regulator in meningioma. Yang Y; Luo L; Zhou Z Aging (Albany NY); 2023 Oct; 15(21):12068-12084. PubMed ID: 37910780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]